MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-14-2026
Grifols, S.A. DIO Ratio 2011-2026 | GRFS
Annual DIO Ratio Grifols, S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 0.000171 | 261 | 263 | 275 | 282 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 282 | 0.000171 | 216 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Esperion Therapeutics
ESPR
|
2.46 K | $ 2.85 | 3.26 % | $ 592 M | USA |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
bluebird bio
BLUE
|
125 | - | - | $ 546 M | USA |
 |
Heron Therapeutics
HRTX
|
644 | $ 0.83 | 3.62 % | $ 138 M | USA |
 |
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | USA |
 |
Avid Bioservices
CDMO
|
102 | - | - | $ 789 M | USA |
 |
China SXT Pharmaceuticals
SXTC
|
216 | $ 1.32 | -5.2 % | $ 1.88 M |  China |
 |
Kala Pharmaceuticals
KALA
|
602 | $ 0.2 | -6.67 % | $ 759 K | USA |